NCT00634452View on ClinicalTrials.gov

Phase 1 Study of MDX-1401 in Patients With CD30-positive Refractory/Relapsed Hodgkin's Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Hodgkin's Lymphomas
Interventions
BIOLOGICAL

MDX-1401

IV weekly for 4 weeks

Trial Locations (6)

10021

Memorial Sloan Kettering Cancer Center, New York

26506

West Virginia University, Morgantown

28207

ClinWorks Cancer Research Center, Charlotte

30322

Winship Cancer Institute, Emory University, Atlanta

60611

Northwestern University Feinberg School of Medicine, Chicago

76508

Scott and White Memorial Hospital and Clinic, Temple

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY